Global Molecular Diagnostics (MDx) Point of Care Market Analysis, 2020

Global Molecular Diagnostics (MDx) Point of Care Market Analysis, 2020

Global Molecular Diagnostics (MDx) Point-of-Care Market Analysis, 2020, By Application (Infectious Disease, Oncology, Hematology, Prenatal Testing, Endocrinology, Others), By Product (Assays, Softwar Read more

  • Healthcare
  • May 2020
  • 193
  • HC10217

Global Molecular Diagnostics (MDx) Point of Care Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of Global Molecular Diagnostics (MDx) Point of Care market which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.

The prevalence of diseases such as infectious diseases in developing countries as well as less developed countries is surging due to improving healthcare infrastructure and the preference of patients for efficient home care. Moreover, suitable government norms and extensive support are also helping in the market growth of MDx Point of Care market. According to MarkNtel Advisors’ research report titled “Global Molecular Diagnostics (MDx) Point of Care Market Analysis, 2020”, the Global Molecular Diagnostics (MDx) Point of Care market is anticipated to grow at a CAGR of around 13% during 2020-25. However, a lack of arrangement with test results obtained from laboratories, strict & tedious approval policies are expected to restrain the market growth. 

Assays are expected to grab the largest market share in the Global Molecular Diagnostics Point of Care market during 2020-25. The assays are uniquely intended for points of care such as hospital critical care units, Specialty clinics, and other healthcare services delivery centers.

North America dominated the Global Mdx Point of Care market in 2019. The same trend is set to prevail during the forecast period. However, the year-on-year growth of Asia-Pacific is set to outperform other geographies during the same period. The region is forecast to grow at a CAGR of around 15.89% during 2020-25, as stated in the MarkNtel Advisors’ research report “Global Molecular Diagnostics (MDx) Point of Care Market Analysis, 2020”.

According to MarkNtel Advisors, Abbott Laboratories, Mesa Biotech, Hologic, Qiagen, F. Hoffmann, Siemens Healthineers, DxNA, Johnson & Johnson, Roche Diagnostics, Danaher Corporation, EKF Diagnostics, Becton Dickinson, Trinty Biotech, and Quidel are few of the leading players in the Global Molecular Diagnostics (MDx) Point of Care Market.

  1. Introduction
    1. Product Definition
    2. Research Process
    3. Glossary
    4. Market Segmentation
  2. Executive Summary
  3. Start-up Ecosystem
  4. Expert Verbatim- Interview Excerpts of 10 industry experts
  5. Global Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Application
        1. Infectious Diseases
        2. Oncology
        3. Hematology
        4. Prenatal Testing
        5. Endocrinology
        6. Others
      2. By Technology
        1. Isothermal Nucleic Acid Amplification Technology (INAAT)
        2. Polymerase Chain Reaction (PCR)
          1. Digital PCR
          2. Real Time PCR
        3. Others
      3. By Product
        1. Assays
        2. Software
        3. Services
      4. By Test-Location
        1. OTC (Over-the-counter)
        2. POC (Point-of-care)
      5. By End-User
        1. Decentralized Labs
        2. Hospitals
        3. Homecare
        4. Assisted Living Healthcare Facilities
        5. Others
      6. By Region
        1. North America
        2. South America
        3. Europe
        4. Asia-Pacific
        5. Middle East & Africa
      7. By Company
        1. Revenue Shares
        2. Strategic Factorial Indexing
        3. Competitor Placement in MarkNtel Quadrant
  6. North America Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Application
      2. By Product
      3. By Test-Location
      4. By End-User
      5. By Technology
      6. By Country
        1. US
        2. Canada
        3. Mexico
    3. US Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    4. Canada Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    5. Mexico Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
  7. South America Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Application
      2. By Product
      3. By Test-Location
      4. By End-User
      5. By Country
        1. Brazil
        2. Argentina
        3. Others
    3. Brazil Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    4. Argentina Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
  8. Europe Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Application
      2. By Product
      3. By Test-Location
      4. By End-User
      5. By Technology
      6. By Country
        1. The UK
        2. Germany
        3. France
        4. Italy
        5. Spain
        6. Others
    3. UK Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    4. Germany Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    5. France Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    6. Italy Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    7. Spain Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
  9. Asia-Pacific Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Application
      2. By Product
      3. By Test-Location
      4. By End-User
      5. By Technology
      6. By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. South Korea
        6. Others
    3. China Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    4. India Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    5. Japan Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    6. Australia Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    7. South Korea Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
  10. Middle East and Africa Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Application
      2. By Product
      3. By Test-Location
      4. By End-User
      5. By Technology
      6. By Country
        1. UAE
        2. Saudi Arabia
        3. Others
    3. UAE Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
    4. Saudi Arabia Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Application
        2. By End-User
  11. Global Molecular Diagnostics (MDx) Point-of-Care Dynamics
    1. Drivers
    2. Challenges
    3. Impact Analysis
  12. Global Molecular Diagnostics (MDx) Point-of-Care Region Wise Regulations, Product Standards
  13. Global Molecular Diagnostics (MDx) Point-of-Care Hotspots & Opportunities
  14. Competition Outlook
    1. Competitor Wise Growth Strategies
      1. Product Portfolio
      2. Brand Specialization
      3. Target Markets
      4. Research & Development
      5. Strategic Alliances & Initiatives
      6. Merges & Acquisitions
    2. Company Profiles
      1. Abbott Laboratories
      2. Mesa Biotech
      3. Hologic, Inc.
      4. QIAGEN N.V
      5.  F. Hoffmann-La Roche Ltd
      6. DxNA LLC Group Ltd
      7. Luminex Corporation
      8. Siemens Healthineers
      9. Johnson & Johnson
      10. Roche Diagnostics
      11. Danaher Corporation
      12. EKF Diagnostics
      13. Becton Dickison
      14. Trinty Biotech
      15. Quidel Corporation
  15. Disclaimer
Global Molecular Diagnostics (MDx) Point of Care Market Segmentation
*This field is required